Whitehawk Therapeutics (WHWK) Payables (2010 - 2026)
Whitehawk Therapeutics (WHWK) posted quarterly Payables of $1.7 million for Q1 2026, down 52.28% year-over-year from $3.7 million in Q1 2025, and up 90.29% quarter-over-quarter from $917000.0 in Q4 2025.
Whitehawk Therapeutics (WHWK) Payables (2010 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has reported Payables for 17 consecutive years, with $1.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Payables fell 52.28% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $1.7 million (down 52.28% YoY), while the FY2025 annual figure was $917000.0, down 57.53% from the prior year.
- Payables rose to $1.7 million in Q1 2026 per WHWK's latest filing, from $917000.0 in the prior quarter.
- Across five years, Payables topped out at $6.5 million in Q1 2023 and bottomed at $917000.0 in Q4 2025.
- Historically, Payables has averaged $3.1 million across 5 years, with a median of $3.1 million in 2024.
- Annual changes were most pronounced in 2022 — Payables surged 774.29% — and 2024, when it tumbled 63.39%.
- Whitehawk Therapeutics' Payables stood at $3.5 million in 2022, then surged by 67.6% to $5.9 million in 2023, then sank by 63.39% to $2.2 million in 2024, then sank by 57.53% to $917000.0 in 2025, then soared by 90.29% to $1.7 million in 2026.
- Business Quant data shows WHWK's Payables at $1.7 million in Q1 2026, $917000.0 in Q4 2025, and $1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Whitehawk Therapeutics | 369.67 Mn | 74.92 Mn | - | 1.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.11 Mn |
| Mar 31, 2026 | 1.75 Mn |
| Dec 31, 2025 | 917,000.00 |
| Sep 30, 2025 | 1.63 Mn |
| Jun 30, 2025 | 3.34 Mn |
| Mar 31, 2025 | 3.66 Mn |
| Dec 31, 2024 | 2.16 Mn |
| Sep 30, 2024 | 1.37 Mn |
| Jun 30, 2024 | 2.27 Mn |
| Mar 31, 2024 | 3.10 Mn |
| Dec 31, 2023 | 5.90 Mn |
| Sep 30, 2023 | 2.61 Mn |
| Jun 30, 2023 | 2.90 Mn |
| Mar 31, 2023 | 6.51 Mn |
| Dec 31, 2022 | 3.52 Mn |
| Sep 30, 2022 | 3.92 Mn |
| Jun 30, 2022 | 3.62 Mn |
| Mar 31, 2022 | 4.01 Mn |
| Dec 31, 2021 | 6.44 Mn |
| Sep 30, 2021 | 5.21 Mn |